» Articles » PMID: 25365067

Successful Early Unmanipulated Haploidentical Transplantation with Reduced-intensity Conditioning for Primary Graft Failure After Cord Blood Transplantation in Hematologic Malignancy Patients

Overview
Specialty General Surgery
Date 2014 Nov 4
PMID 25365067
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Primary graft failure (pGF) is a frequent complication following cord blood transplantation (CBT). For those patients who will not experience autologous recovery, salvage transplantation should be performed as early as possible. However, standardized treatment protocols for pGF, such as the optimal stem cell source, preparative regimen and the ideal time for salvage transplantation, have yet to be determined. Therefore, we analyzed 17 hematologic malignancy patients who received unmanipulated haploidentical peripheral blood (PB) and BM transplantation with reduced-intensity conditioning (RIC) as a salvage therapy for pGF after CBT. The median interval between the two transplantations was 38 days. The RIC regimen for salvage transplantation consisted of fludarabine, antithymocyte globulin, CY and low-dose TBI. The neutrophil and plt engraftments were achieved in 14 (82.4%) and 13 (76.4%) patients, respectively. The cumulative incidences of grades II-IV and grades III-IV aGVHD were 35.3% and 17.6%, respectively. The cumulative incidence of chronic GVHD was 29.4%. After a median follow-up of 43 months, 10 of 17 patients remained alive in CR. The cumulative incidence of TRM at 180 days was 29.4%. The probability of 3-year OS and leukemia-free survival was 57.5%. Our results show that unmanipulated haploidentical PB and BM transplantation under a RIC regimen is an effective treatment for pGF after CBT.

Citing Articles

Graft Failure in Patients With Hematological Malignancies: A Successful Salvage With a Second Transplantation From a Different Haploidentical Donor.

Sun Y, Wang Y, Wang F, Yan C, Cheng Y, Chen Y Front Med (Lausanne). 2021; 8:604085.

PMID: 34150785 PMC: 8212968. DOI: 10.3389/fmed.2021.604085.


Salvage HLA-haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide for graft failure in non-malignant disorders.

Albert M, Sirin M, Hoenig M, Hauck F, Schuetz C, Bhattacharyya R Bone Marrow Transplant. 2021; 56(9):2248-2258.

PMID: 33967276 PMC: 8106764. DOI: 10.1038/s41409-021-01323-9.


Comparison of the outcomes after haploidentical and cord blood salvage transplantations for graft failure following allogeneic hematopoietic stem cell transplantation.

Harada K, Fuji S, Seo S, Kanda J, Ueki T, Kimura F Bone Marrow Transplant. 2020; 55(9):1784-1795.

PMID: 32051535 DOI: 10.1038/s41409-020-0821-9.


Haploidentical hematopoietic stem cell transplantation in a myelofibrosis patient with primary graft failure.

Tecchio C, Andreini A, Costantini C, Zamo A, de Sabata D, Aprili F Hematol Rep. 2018; 9(4):7091.

PMID: 29383224 PMC: 5768082. DOI: 10.4081/hr.2017.7091.

References
1.
Yoshihara S, Ikegame K, Taniguchi K, Kaida K, Kim E, Nakata J . Salvage haploidentical transplantation for graft failure using reduced-intensity conditioning. Bone Marrow Transplant. 2011; 47(3):369-73. DOI: 10.1038/bmt.2011.84. View

2.
Lu D, Dong L, Wu T, Huang X, Zhang M, Han W . Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood. 2005; 107(8):3065-73. DOI: 10.1182/blood-2005-05-2146. View

3.
Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A . Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004; 351(22):2276-85. DOI: 10.1056/NEJMoa041469. View

4.
Narimatsu H, Matsumura T, Kami M, Miyakoshi S, Kusumi E, Takagi S . Bloodstream infection after umbilical cord blood transplantation using reduced-intensity stem cell transplantation for adult patients. Biol Blood Marrow Transplant. 2005; 11(6):429-36. DOI: 10.1016/j.bbmt.2005.01.010. View

5.
Wagner J, Gluckman E . Umbilical cord blood transplantation: the first 20 years. Semin Hematol. 2010; 47(1):3-12. DOI: 10.1053/j.seminhematol.2009.10.011. View